Sperm changes in Hodgkin lymphoma
Part of Cancer clinical trials.
This study looks at how Hodgkin lymphoma and its treatment (ABVD or BrECADD) affect sperm at a molecular level. It may help doctors understand and protect fertility in men with this cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 45 years old.
- You have been diagnosed with Hodgkin lymphoma.
- You have not yet had any chemotherapy or other cancer-killing treatment.
- Your planned treatment is either ABVD or BrECADD (two specific chemotherapy regimens).
- You do not need radiation therapy to your belly area.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at fertility outcomes in young men who had cancer or blood disorders as children and then received high-risk treatment that can affect future fertility. It also compares people who did or did not store testicular tissue through a biopsy when they were younger.
This study examines testicular function and semen quality in men who were treated for cancer before age 18 and are now in remission. It aims to understand how childhood cancer treatments affect long-term fertility.
This trial tests a new treatment where your own immune cells are modified to better attack Hodgkin lymphoma cells. It is for people whose disease has not responded to other therapies.
This trial studies a treatment plan for children with classical Hodgkin lymphoma that uses lower total doses of chemotherapy and reduced radiation. The goal is to help control the lymphoma while lowering long-term side effects.
This study tests a combination of the immunotherapy drug pembrolizumab with a chemotherapy regimen called GVD for patients whose Hodgkin's lymphoma has not responded or has returned after initial treatment. The goal is to see if this combination works better than standard approaches.
This study measures how anti-cancer treatment affects a person’s egg reserve (for women) or semen quality (for men) over time. It may help doctors better understand fertility-related side effects of melanoma therapy and how they evolve during routine treatment.
Hear when a new Hodgkin Disease Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.